Pentadecapeptide BPC
Tissue Repair- Molecular Formula
- C62H98N16O22
- Molar Mass
- 1,419.5 g/mol
- CAS Number
- 137525-51-0
- Purity Standard
- 99%+ (HPLC Verified)
- Amino Acid Sequence
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Overview
Pentadecapeptide BPC (Body Protection Compound) is the core 15-amino acid sequence identified from the larger BPC protein isolated from human gastric juice. This peptide fragment represents the biologically active portion responsible for the gastroprotective and tissue-healing properties observed in studies of the parent protein. It is chemically identical to BPC-157.
The discovery of BPC originated from investigations into the protective factors present in gastric juice that maintain mucosal integrity despite the harsh acidic environment. Researchers identified a protein that demonstrated remarkable cytoprotective properties, and subsequent fractionation revealed that a specific 15-amino acid fragment retained full biological activity.
Pentadecapeptide BPC exhibits extraordinary stability in gastric juice, a property unusual for peptides and essential for its physiological role in gastrointestinal protection. This stability is attributed to its specific amino acid sequence and the absence of sites susceptible to common proteolytic enzymes active in the stomach.
Research has demonstrated pentadecapeptide BPC's effects extend far beyond gastrointestinal protection. The compound influences multiple healing pathways including growth factor expression (particularly EGF and VEGF), nitric oxide synthesis, and GABAergic neurotransmission. These pleiotropic effects have led to investigation in diverse tissue repair contexts including tendon, muscle, bone, and nervous system injury models.
Synthesis Overview
Pentadecapeptide BPC is synthesized via Fmoc solid-phase peptide synthesis using standard protocols optimized for this 15-amino acid sequence. The synthesis proceeds from C-terminus to N-terminus on a resin support, with iterative cycles of Fmoc deprotection and amino acid coupling. The proline-rich sequence (three consecutive prolines) requires attention to prevent deletion sequences. Following TFA cleavage and global deprotection, the crude peptide is purified via preparative reverse-phase HPLC. Quality control includes mass spectrometry for molecular weight confirmation, HPLC purity analysis (>99%), and amino acid analysis to verify composition.
Research Applications
- Gastric cytoprotection and ulcer healing mechanism studies
- Gastrointestinal mucosal integrity and barrier function research
- Growth factor pathway modulation investigation
- Nitric oxide synthesis regulation and vascular healing studies
- Tendon, ligament, and musculoskeletal tissue repair research
- Dopaminergic and serotonergic system interaction studies
Related Compounds
C212H350N56O78S
4,963.5 g/mol
Thymosin Beta-4 (Tbeta4) is a 43-amino acid naturally occurring peptide that serves as the primary intracellular G-actin sequestering protein. By bind...
View Full ProfileC62H98N16O22
1,419.5 g/mol
BPC-157 Arginate is a salt form variant of the Body Protection Compound-157 pentadecapeptide, formulated with L-arginine as the counterion instead of ...
View Full ProfileC62H98N16O22
1,419.53 g/mol
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a naturally occurring protein found in human gastric juice. It con...
View Full Profile